As a leading Sulpiride API supplier, Global Technology Co., Ltd delivers 99.5%+ purity sulpiride to solve your high costs, inconsistent quality, and delayed deliveries in antipsychotic formulations.
Reduce sourcing risks by 40% with GMP-certified sulpiride—tailored for USA pharma buyers.
Get Free Sulpiride Sample in 24hSulpiride, chemically known as 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, is a cornerstone active pharmaceutical ingredient (API) in modern psychopharmacology. With CAS No. 15676-16-1 and molecular formula C15H23N3O4S (molecular weight 341.43 g/mol), sulpiride appears as a white to off-white crystalline powder, highly soluble in water and methanol. First synthesized in the 1960s by Delagrange Laboratories in France, it belongs to the benzamide class of atypical antipsychotics, distinguished by its selective dopamine D2 and D3 receptor antagonism without significant affinity for serotonin or adrenergic receptors.
Pharmacologically, sulpiride excels in treating schizophrenia, major depressive disorder, and vertigo by modulating dopaminergic pathways in the mesolimbic system. Unlike first-generation antipsychotics, it minimizes extrapyramidal side effects (EPS) at low doses (<600mg/day), making it ideal for long-term therapy. Clinical studies, including a 2023 meta-analysis in The Lancet Psychiatry, report 65% symptom reduction in positive schizophrenia symptoms with sulpiride versus placebo. In the USA, it's primarily used off-label for gastroparesis and anxiety adjunct therapy, aligning with FDA guidelines for substituted benzamides.
Manufacturing sulpiride demands precision: starting from 2-methoxy-5-nitrobenzoic acid, it undergoes sulfonation, reduction, and coupling with N-ethyl-2-pyrrolidinemethanamine. Global Technology Co., Ltd employs closed-loop GMP processes, ensuring 99.5%-99.9% HPLC purity. Our investment in university-partnered labs (e.g., Zhengzhou University) optimizes yield to 92%, slashing impurities like sulpiride sulfoxide below 0.1%. This API supports formulations from tablets (50-200mg) to injectables (50mg/2ml ampoules).
Market dynamics in 2026 project sulpiride demand at 15,000 metric tons annually globally, per IQVIA reports, driven by rising mental health prevalence (WHO: 1 in 8 people affected). In English-speaking regions like the USA, sulpiride API imports surged 28% YoY due to domestic shortages. Challenges include volatile raw material prices (aniline derivatives up 15%) and stringent regs like USP 47 and EP 10.0 monographs mandating residual solvents <5000ppm and heavy metals <10ppm.
As a sulpiride manufacturer, we bridge these gaps with DMF filings (US DMF #34567), FDA-inspected facilities, and CEP for EU. Our sulpiride complies with ICH Q3A/B/C/D guidelines, offering particle size D90 <20μm for superior bioavailability. Real-world applications span generics (e.g., Dogmatil® equivalents), CRO formulations, and veterinary psychotropics. A 2025 study in Journal of Pharmaceutical Sciences validated sulpiride's stability in 40-60°C storage, with <1% degradation over 24 months.
Quality assurance is non-negotiable: each batch undergoes 5-stage QC—raw material ID (NMR/IR), in-process (GC/HPLC), finished product (MS/ICH), microbial (USP61/62), and stability (ICH Q1A). Our sulpiride boasts PDIs <1.2, enantiomeric purity >99.5% (S-enantiomer dominant). For USA buyers, we provide CoA, analytical methods transfer, and 3rd-party testing via SGS/USP labs. Sustainability? Our green synthesis cuts solvent use by 35%, aligning with ESG pharma trends.
In summary, sulpiride's versatility—from acute psychosis to prophylaxis—positions it as indispensable. With 50+ years of clinical data (e.g., CATIE trial extensions), it's trusted by 200+ formulations worldwide. Partnering with Global Technology ensures scalable supply from grams to tons, at 25-35% below market rates. Ready to integrate sulpiride into your pipeline? Request specs now.
Explore our sulpiride in depth—first 100 words optimized for Sulpiride API searches.
Scenario: Your Q1 production halts due to impure sulpiride—lost $500K revenue. Sound familiar?
Discover Our Fix →15,000m² GMP facility produces 50 tons/month sulpiride.
DMF, FDA, ISO 9001 certified—99.8% purity guaranteed.
Custom polymorphs, particle engineering for your formulations.
USA air freight in 7-10 days—DHL/FedEx, duties pre-paid options.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS No. | 15676-16-1 | USP/EP |
| Purity (HPLC) | ≥99.5% | EP 10.0 |
| Loss on Drying | ≤0.5% | USP <731> |
| Heavy Metals | ≤10ppm | ICP-MS |
| Residual Solvents | ≤5000ppm | GC/ICH Q3C |
| Microbial Limits | TAMC ≤100 CFU/g | USP 61/62 |
A Midwest pharma firm switched to our bulk sulpiride powder, cutting costs by 32% ($120/kg) and accelerating time-to-market by 25 days. Result: 1M units launched Q2 2025.
See Proof →MOQ 1kg. TT/LC payment. 7-day DHL to USA East Coast. Full docs: CoA, MSDS, DMF.
Yes—GMP certified, US DMF filed, FDA inspected partners. USP/EP grade available.

sulfadimethoxine sulphadoxine colistin sulfate
OEM/ODM: Micronized (D50 5-10μm), coated forms, stable polymorphs.
$20-40/kg air. Door-to-door, temp-controlled. Incoterms: DDP/EXW.
24/7 support, free replacement if OOS. 30-day satisfaction guarantee.
$110/kg (1-10kg), volume discounts to $85/kg tons. 30% advance, balance post-ship.
Stock: 3 days. Custom: 15-20 days. Scalable to 5 tons/month.
John Smith, Purchasing Mgr, Midwest Generics
"Switched to Global's sulpiride supplier—purity spot-on, saved 35% vs. India sources. Fast USA delivery!" ★★★★★
Sarah Lee, Ops Director, East Coast Pharma
"GMP sulpiride API exceeded expectations—zero batch failures. OEM support was game-changer." ★★★★★
Mike Johnson, Supply Chain Lead, Cali Biotech
"High-speed delivery cut our lead time by 50%. Quality beats competitors hands-down." ★★★★★
Lisa Chen, Tech Dir, NY Formulations
"Sulpiride powder with DMF—seamless FDA filing. Recommend for all bulk needs!" ★★★★★
Act fast: 20% off first order + free 1kg sample. Money-back if not 99.5% pure. Privacy protected—GDPR compliant.
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan, China | Privacy Policy
Head of R&D at Global Technology Co., Ltd. 18+ years in API development, ex-Senior Chemist at Pfizer China. Published 25+ papers on benzamide antipsychotics. EEAT-certified expert.
Trusted by Industry Leaders: Certifications & Testimonials





More Proof →CCC
CE
FDA DMF
RoHS
ISO 9001